Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Investors
Resources
Sample Case Studies
Clinical Research Repository
Customer Support
Solutions
Use Cases
Healthcare
Drug and Device Development
Academia/Research
Wellness and Longevity
Therapies
Hypertension
Renal Disease
Heart Failure
Maternal Health
Brain Health
Metabolic Health
COPD
Men’s Health
Sports Medicine
Products
CONNEQT Pulse
SphygmoCor XCEL
Oscar 2
Digital Solutions
SphygmoCor Technology
Company
About
Board & Management
Corporate Governance
News & Media
Events & Tradeshows
Technology & IP
Careers
Investors
Resources
Case Studies
Clinical Research Repository
Customer Support
Legal
Privacy Policy
Disclaimer
Acceptable Use Policy
Contact Us
✕
No results
See all results
PDF
June 4, 2019
June 4, 2019
CardieX Technology Validated in Chinese Clinical Study
June 4, 2019
June 4, 2019
Achievement of First CEO Performance Rights Hurdle
June 4, 2019
June 4, 2019
Senior Health Executive Appointed to Cardiex Advisory Board
June 4, 2019
June 4, 2019
Results of Extraordinary General Meeting
June 4, 2019
June 4, 2019
Final Director’s Interest Notice
June 4, 2019
June 4, 2019
Transition of Directors & New Interim Chairman Appointment
June 4, 2019
June 4, 2019
Half Year Accounts
June 4, 2019
June 4, 2019
Appendix 4D Half Year Report
June 4, 2019
June 4, 2019
CardieX Announces Expansion of Bayer Pharma Trial Contract
Load more
Contact Us
No results
See all results